Equities

Fonar Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
FONR:NAQ

Fonar Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)18.54
  • Today's Change-0.04 / -0.22%
  • Shares traded71.98k
  • 1 Year change+14.44%
  • Beta0.9885
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, hiring, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.

  • Revenue in USD (TTM)105.43m
  • Net income in USD6.99m
  • Incorporated1978
  • Employees535.00
  • Location
    Fonar Corp110 Marcus DrMELVILLE 11747-4228United StatesUSA
  • Phone+1 (631) 694-2929
  • Fax+1 (631) 753-5150
  • Websitehttps://www.fonar.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Alpha Teknova Inc39.80m-18.22m112.95m173.00--1.55--2.84-0.3409-0.34090.74461.360.34353.778.17230,063.60-15.73-19.57-16.94-20.9730.9738.24-45.78-63.704.27-28.650.1525--2.8912.6827.28---16.96--
Picard Medical Inc4.77m-33.80m118.66m75.00--14.89--24.86-0.4673-0.46730.0660.1081------63,653.33---------10.03---660.85--0.9373-0.78080.0134---12.93---31.86------
Pro-Dex Inc70.23m11.19m121.92m181.0011.352.999.801.743.353.3521.0312.731.182.654.40388,016.6018.8712.0623.8815.2428.0929.8115.9411.732.14--0.24180.0023.6813.84322.107.9919.14--
Neuronetics Inc129.87m-44.50m123.27m716.00--4.50--0.9492-0.8344-0.83442.240.39971.1813.877.31181,386.90-40.63-29.61-52.56-36.9650.4374.98-34.35-53.712.09-4.310.6768--4.963.63-44.78--12.51--
Treace Medical Concepts Inc218.88m-50.11m128.71m477.00--1.44--0.588-0.7947-0.79473.481.401.071.047.66458,865.80-24.47-24.03-30.34-29.1779.8780.99-22.89-24.972.36-22.690.3829--11.8939.65-12.55--57.11--
Fonar Corp105.43m6.99m136.58m535.0017.840.6969.741.301.041.0415.7426.690.489722.331.28197,073.504.346.774.427.1941.0745.468.8613.748.46--0.0021--1.434.02-21.260.1719-12.96--
LifeMD Inc252.34m-7.71m140.08m304.00--103.1528.370.5551-0.1711-0.17115.660.02823.6410.8333.00830,075.60-4.29-109.71-31.14-396.0386.9685.59-1.18-33.120.66450.31640.00--39.2776.327.23------
Cibus Inc3.79m-118.90m141.91m157.00--2.18--37.40-3.26-3.260.09720.95880.0109--4.2324,165.61-36.11-80.24-39.32-89.98-----3,322.54-1,268.46---2.180.8131--134.56-10.196.07---22.92--
Citrine Global Corp0.00-1.74m141.93m18.00---------0.0016-0.00160.00-0.00310.00----0.00-118.80-238.43-----------186,483.40---2.10--------25.99------
Anika Therapeutics Inc82.20m13.91m147.82m288.0010.881.017.311.800.9419-2.285.7010.180.39070.4863.25285,430.606.61-1.877.39-2.0654.2960.7416.92-4.734.47--0.00---0.73270.9077-156.70--24.14--
LENSAR Inc59.14m-51.52m148.35m140.00------2.51-4.39-4.394.99-1.020.89461.7911.51422,435.70-77.94-32.69-121.49-38.9546.1551.51-87.12-54.770.6671------26.8711.87-118.34---40.48--
InfuSystem Holdings Inc141.05m5.52m154.76m502.0029.092.798.171.100.26160.26166.652.731.3810.255.79280,984.105.414.506.565.4655.3555.243.923.861.607.730.2740.007.2210.70168.9211.50-4.62--
Nano-X Imaging Ltd12.30m-55.71m155.03m165.00--0.9346--12.60-0.8839-0.88390.1952.400.068313.177.1874,557.58-30.95-28.17-33.30-31.20-98.04---452.82-1,072.253.93--0.0201--13.91--11.95--85.79--
Lucid Diagnostics Inc4.40m-65.84m157.11m72.00------35.71-0.8968-0.89680.05260.19730.116112.2414.9461,097.22-140.60-139.37-301.55-297.39-58.13---1,211.30-2,492.791.88--0.4633--79.00---0.6817------
CVRx Inc55.97m-52.02m159.36m206.00--3.31--2.85-2.02-2.022.181.830.46840.74586.49271,694.20-43.53-37.08-47.98-40.0284.4981.33-92.95-151.188.60-8.490.5072--30.5352.31-45.55--66.61--
Apyx Medical Inc47.90m-14.54m160.78m220.00--25.35--3.36-0.3644-0.36441.190.15460.81131.973.68217,736.40-24.60-27.67-29.90-33.3562.6564.81-30.32-43.613.61-2.040.8507---8.1111.24-25.38---11.11--
Data as of Feb 12 2026. Currency figures normalised to Fonar Corp's reporting currency: US Dollar USD

Institutional shareholders

40.00%Per cent of shares held by top holders
HolderShares% Held
Kayne Anderson Rudnick Investment Management LLCas of 30 Sep 2025536.99k8.66%
Money Concepts Capital Corp.as of 31 Dec 2025510.67k8.23%
Dimensional Fund Advisors LPas of 30 Sep 2025361.26k5.82%
The Vanguard Group, Inc.as of 31 Dec 2025323.62k5.22%
Renaissance Technologies LLCas of 30 Sep 2025308.62k4.98%
Peapod Lane Capital LLCas of 31 Dec 2025104.87k1.69%
BlackRock Fund Advisorsas of 30 Sep 202590.75k1.46%
Truffle Hound Capital LLCas of 30 Sep 202590.00k1.45%
Bridgeway Capital Management LLCas of 30 Sep 202581.19k1.31%
RBF Capital LLCas of 30 Sep 202573.06k1.18%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.